Prof. Dr. med. Peter Fasching



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020. (2020) Ditsch N, Untch M, Kolberg-Liedtke C, Jackisch C, Krug D, Friedrich M, Janni W, et al. Journal article, Review article Neoadjuvant paclitaxel/olaparib in comparison to paclitaxel/carboplatinum in patients with HER2-negative breast cancer and homologous recombination deficiency (GeparOLA study) (2020) Fasching P, Link T, Hauke J, Seither F, Jackisch C, Klare P, Schmatloch S, et al. Journal article Genetic variations in estrogen and progesterone pathway genes in preeclampsia patients and controls in Bavaria (2020) Pretscher J, Rübner M, Ekici AB, Rödl M, Hübner H, Schwitulla J, Titzmann A, et al. Journal article Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setup (2020) Emons J, Fasching P, Wunderle M, Heindl F, Rieger J, Horn F, Pelzer G, et al. Journal article Genetic variants in the glucocorticoid pathway genes and birth weight (2020) Schneider M, Hübner T, Pretscher J, Goecke TW, Schwitulla J, Häberle L, Kornhuber J, et al. Journal article MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial (2020) Jank P, Gehlhaar C, Bianca L, Caterina F, Andreas S, Karn T, Marmé F, et al. Journal article Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center in Relation to Complementary and Alternative Medicine (2020) Hack C, Wasner S, Meyer J, Häberle L, Jud S, Hein A, Wunderle M, et al. Journal article Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center Regarding Consensus between the First and Second Opinion and Conformity with the Guidelines (2020) Lux MP, Wasner S, Meyer J, Häberle L, Hack C, Jud S, Hein A, et al. Journal article Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients (2020) Erber R, Rübner M, Davenport S, Hauke S, Beckmann M, Hartmann A, Häberle L, et al. Journal article Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer (2020) Kho PF, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann M, et al. Journal article